Tag Archives: Purdue Pharma

Prescription Opioids: American Addiction Epidemic

prescription opioids

The number of overdose deaths involving opioids has skyrocketed over the past two decades. Prescription opioids, heroin, and illicit fentanyl carry significant risks for the user; a slight miscalculation in dosing can have fatal outcomes.

Most experts agree that prescription opioids are responsible for the addiction epidemic in America. While it’s somewhat more challenging to acquire narcotics like oxycodone or OxyContin, many doctors continue to prescribe them for all things pain.

We have written about the American opioid addiction epidemic on numerous occasions. We recently shared about the maker of OxyContin – Purdue Pharma – agreeing to plead guilty to criminal charges for its role in the public health crisis involving opioids.

Towards the end of November, a federal bankruptcy judge authorized a settlement between the Justice Department and Purdue valued at $8.3 billion, NPR reports. Purdue will plead guilty to three felony counts of criminal wrongdoing.

In our previous post on the subject, we pointed out that Purdue is one of many companies facing a litany of lawsuits for playing a pivotal role in the opioid epidemic. Thousands of lawsuits are pending against narcotic manufacturers and prescription drug distributors alike.

Both state and local governments want to hold companies that have made billions of dollars from the sale of prescription opioids accountable. Lawsuits suggest that ‘big pharma’ knew their products were both addictive and deadly but continued to market them as safe aggressively. What’s more, prescription drug distributors filled suspiciously large orders of narcotics to pharmacies across the country.

Prescription Opioids En Masse

As mentioned above, Purdue Pharma doesn’t stand alone in creating one of the most severe public health crises of our time. Other companies like Johnson & Johnson and three drug distributors are negotiating settlements to end thousands of lawsuits relating to the opioid epidemic, The New York Times reports. If the settlement is approved, billions of dollars will go towards addiction treatment and prevention in areas hardest hit by opioids and overdose.

McKesson, Cardinal Health, AmerisourceBergen, and Johnson & Johnson are working on a $26 billion deal that could shield the companies from any further litigation, according to the article. The three distributors were responsible for filling more than three-quarters of the nation’s opioids orders to pharmacies.

Moreover, the companies largely disregarded suspicious orders, such as shipping enormous quantities of opioids to pharmacies that serviced small populations. For instance, the distributors shipped 21 million prescription opioids to two pharmacies in a West Virginia town of 2,900 people over ten years.

The settlement offer is $4 billion more than the offer made by the companies last year, according to the article. The distributors would pay $21 billion over 18 years, whereas Johnson & Johnson would pay $5 billion. Part of the companies’ settlement includes an agreement to strengthen drug monitoring programs.

The deal gets money to all of the communities in the United States that are suffering from insult upon injury, first from the opioid epidemic and now with Covid as well,” said Paul J. Hanly Jr., a lawyer representing several small governments. He adds, “We believe it’s in the best interest of these communities to begin receiving a payment stream. We looked at the finances of these companies and believe the numbers are now appropriate.”

Heroin and Fentanyl

America constitutes about five percent of the global population but consumes approximately 80 percent of the global opioid supply, CNBC reports. According to the Centers for Disease Control and Prevention (CDC), 232,000 Americans died from overdoses of prescription opioids from 1999 through 2018. Research shows that roughly 80 percent of people who use heroin first misused prescription opioids.

Prescription painkillers have long been the gateway to illicit opioid use. Heroin and fentanyl are responsible for tens of thousands of opioid overdose deaths. The latter has made many headlines in recent years; fentanyl is often mixed into heroin to boost potency. Fentanyl is also sought out and used purposely.

Fentanyl is often the cause of fatal overdoses, and new research suggests that such deaths are on the rise in the western United States. Cities like Los Angeles, Phoenix, and Seattle have been significantly affected, NPR reports. The increase of fentanyl use in the west contributed to the 72,000 overdose deaths in America last year.

Up through 2018, the vast majority of synthetic opioid overdoses occurred east of the Mississippi River,” said study author Chelsea Shover, an epidemiologist at Stanford University. She adds, “You think you’re using heroin or you think you’re using Ecstasy or Xanax or what looks like an OxyContin pill, but it’s actually fentanyl.”

Opioid Use Disorder Treatment for Men

If you are struggling with prescription opioids, heroin, or fentanyl, PACE Recovery Center can help. We specialize in the treatment of men who are battling addiction and mental illness. We can help you or a loved one get on the path to recovery. Please contact us today to learn more about our programs and services.

Opioid Addiction Epidemic in America

opioid addiction

The American opioid addiction epidemic has been relegated to the back burner of late because of the COVID-19 pandemic. That’s not to say opioid addiction and overdose are no longer on the radar; it’s that we’ve been caught up in COVID-19 statistics and our government’s plan to address the situation.

As far as public health crises are concerned, it makes sense that our focus has shifted to the coronavirus—it has stolen more than 220,000 lives in 2020 thus far. Still, the opioid use disorder epidemic should not be forgotten about, even if it’s challenging to focus on more than one public health crisis at a time.

For years, it seemed like opioid addiction and overdoses dominated the headlines; that nearly 100,000 Americans die of an overdose each year seemed like a primary topic of discussion. With each passing week, a new headline involving opioids would be seen having to do with misuse or a new lawsuit against those who profited from overprescribing. However, public attention has pivoted to COVID-19, which has led to more than one million deaths worldwide.

With the nation’s attention on coronavirus, many important stories are being overlooked. You may have missed specific headlines, like the one involving Purdue Pharma and the Sackler family.

The Sackler family, which owns Purdue Pharma, has been in the limelight in recent years. The primary shareholders of the makers of OxyContin are infamous in America. You may be aware that Purdue touted OxyContin as not carrying a significant risk for addiction. The drug was promoted to prescribers as being safe, despite the steady rise in overdoses since the release of the drug in the mid-’90s.

Purdue’s Role in the Nation’s Opioid Crisis

Last week, Purdue Pharma agreed to plead guilty to criminal charges related to its marketing practices, The New York Times reports. The company is looking at $8.3 billion in penalties, and the Sacklers have agreed to pay $225 million in civil penalties.

In recent years, thousands of thousands of lawsuits have been brought against Purdue Pharma. States, cities, counties, and tribes are all trying to hold the company and the Sackler family responsible for their role in the nation’s opioid addiction epidemic. The vast majority of people using heroin today used prescription opioids like OxyContin first.

Research shows that 21% of high school seniors who misused prescription opioids and later received an opioid prescription, used heroin by age 35.

While this update is promising news, it’s unlikely that Purdue will pay anything close to the $8 billion; the company has already sought bankruptcy court protection, according to the article. However, the settlement could lead to the resolution of many of the thousands of pending lawsuits. The agreement did not end all the litigation against Purdue, nor does it preclude the filing of criminal charges against Purdue Pharma executives or individual Sacklers.

In a letter to the Department of Justice, relatives of opioid use disorder victims said the agreement falls short. What’s more, Massachusetts has scheduled depositions against some Sacklers for next month.

The D.O.J. failed,” said Maura Healey, the Massachusetts attorney general. “Justice in this case requires exposing the truth and holding the perpetrators accountable, not rushing a settlement to beat an election. I am not done with Purdue and the Sacklers, and I will never sell out the families who have been calling for justice for so long.”

Opioid Addiction During the Pandemic

Purdue Pharma and the Sacklers are the tip of the iceberg. Lawsuits have been filed against other drug companies, including prescription drug distributors that filled pharmacy orders despite evidence of impropriety. The opioid addiction epidemic is nuanced; many players were involved in the problem becoming this bad.

The pandemic has made matters worse, according to a new Quest Diagnostics Health Trends study. The research shows that misuse of fentanyl, heroin, and non-prescribed opioids are on the rise.

The findings indicate that the drug positivity rate increased 35% for non-prescribed fentanyl and 44% for heroin during the pandemic compared to the period before the pandemic (January 1, 2019-March 14, 2020 and March 15-May 16, 2020).

The COVID-19 pandemic has created the perfect storm for a rise in substance use disorders and other forms of prescription and illicit drug misuse. Stress, job losses and depression compounded with isolation and a lack of access to health services can trigger prescription medication overuse, illicit drug use, or relapses,” said co-author Harvey W. Kaufman, M.D., Senior Medical Director, Head of Health Trends Research Program, Quest Diagnostics.

It was concerning to learn that the positivity for a combination of drugs was especially pronounced. Positivity for non-prescribed fentanyl and amphetamines increased by 89%, benzodiazepines (48%), cocaine (34%), and opiates (39%). The researchers point out that most overdoses involve concurrent use of benzodiazepines, cocaine, or methamphetamine.

Our Health Trends data demonstrate the consequences of the pandemic, with dramatic increases of misuse of non-prescribed drugs at a time when fentanyl is also on the rise. Our nation is grappling with a drug epidemic inside a pandemic. Patients and providers need increased access to support services, clinical care and drug testing to stop drug misuse from claiming more lives,” Dr. Kaufman said.

Opioid Use Disorder Treatment for Men

Please contact PACE Recovery Center if you or a loved one is struggling with an opioid use disorder. Our team utilizes evidence-based therapies to help our clients break the cycle of addiction and learn how to lead a positive life in recovery. We are standing by at 800-526-1851 to answer any questions you have about our gender-specific treatment for men.

Contact Us

...
PACE Recovery Center is an essential business. Click for more information about PACE's COVID-19 protocols and residential treatment options during COVID-19.
close